Block-and-lock: new horizons for a cure for HIV-1
I Moranguinho, ST Valente - Viruses, 2020 - mdpi.com
HIV-1/AIDS remains a global public health problem. The world health organization (WHO)
reported at the end of 2019 that 38 million people were living with HIV-1 worldwide, of which …
reported at the end of 2019 that 38 million people were living with HIV-1 worldwide, of which …
Block and lock HIV cure strategies to control the latent reservoir
CL Ahlenstiel, G Symonds, SJ Kent… - Frontiers in cellular and …, 2020 - frontiersin.org
The HIV latent reservoir represents the major challenge to cure development. Residing in
resting CD4+ T cells and myeloid cells at multiple locations in the body, including sanctuary …
resting CD4+ T cells and myeloid cells at multiple locations in the body, including sanctuary …
Insights into persistent HIV-1 infection and functional cure: novel capabilities and strategies
TM Ta, S Malik, EM Anderson, AD Jones… - Frontiers in …, 2022 - frontiersin.org
Although HIV-1 replication can be efficiently suppressed to undetectable levels in peripheral
blood by combination antiretroviral therapy (cART), lifelong medication is still required in …
blood by combination antiretroviral therapy (cART), lifelong medication is still required in …
Defective HIV-1 genomes and their potential impact on HIV pathogenesis
J Kuniholm, C Coote, AJ Henderson - Retrovirology, 2022 - Springer
Defective HIV-1 proviruses represent a population of viral genomes that are selected for by
immune pressures, and clonally expanded to dominate the persistent HIV-1 proviral genome …
immune pressures, and clonally expanded to dominate the persistent HIV-1 proviral genome …
Deep latency: A new insight into a functional HIV cure
Latent HIV reservoir is the main obstacle that prevents a cure for HIV-1 (HIV). While
antiretroviral therapy is effective in controlling viral replication, it cannot eliminate latent HIV …
antiretroviral therapy is effective in controlling viral replication, it cannot eliminate latent HIV …
The block-and-lock strategy for human immunodeficiency virus cure: lessons learned from didehydro–cortistatin A
Antiretroviral therapy effectively controls human immunodeficiency virus (HIV) infection.
However, a reservoir of latently infected cells persists under suppressive therapy …
However, a reservoir of latently infected cells persists under suppressive therapy …
Oregano oil and its principal component, carvacrol, inhibit HIV-1 fusion into target cells
S Mediouni, JA Jablonski, S Tsuda… - Journal of …, 2020 - Am Soc Microbiol
Oregano essential oil has long been known for its health-promoting benefits. Here, we report
its activity against viral replication. Oregano oil was found to specifically inhibit lentiviruses …
its activity against viral replication. Oregano oil was found to specifically inhibit lentiviruses …
Forging a functional cure for HIV: transcription regulators and inhibitors
S Mediouni, S Lyu, SM Schader, ST Valente - Viruses, 2022 - mdpi.com
Current antiretroviral therapy (ART) increases the survival of HIV-infected individuals, yet it is
not curative. The major barrier to finding a definitive cure for HIV is our inability to identify …
not curative. The major barrier to finding a definitive cure for HIV is our inability to identify …
Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
C Li, G Mousseau, ST Valente - Epigenetics & chromatin, 2019 - Springer
Background Transcription from the integrated HIV-1 promoter is directly governed by its
chromatin environment, and the nucleosome-1 downstream from the transcription start site …
chromatin environment, and the nucleosome-1 downstream from the transcription start site …
Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND
J Marino, ME Maubert, AR Mele, C Spector… - Cellular and Molecular …, 2020 - Springer
Human immunodeficiency virus type 1 (HIV-1) transactivator of transcription (Tat) is a potent
mediator involved in the development of HIV-1-associated neurocognitive disorders …
mediator involved in the development of HIV-1-associated neurocognitive disorders …